Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BERNHARDT, Günther")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

Tetrahydroxy 10-membered cyclic enediynesKLEIN, Michael; ZABEL, Manfred; BERNHARDT, Günther et al.Journal of organic chemistry. 2003, Vol 68, Num 24, pp 9379-9383, issn 0022-3263, 5 p.Article

Polyvinyl butyral nanobeads: preparation, characterization, biocompatibility and cancer cell uptakePOSAVEC, Damir; DORSCH, André; BOGNER, Udo et al.Mikrochimica acta (1966. Print). 2011, Vol 173, Num 3-4, pp 391-399, issn 0026-3672, 9 p.Article

NG-Acyl-argininamides as NPY Y1 receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinityWEISS, Stefan; KELLER, Max; BERNHARDT, Günther et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 17, pp 6292-6304, issn 0968-0896, 13 p.Article

Novel 6-O-acylated vitamin C derivatives as hyaluronidase inhibitors with selectivity for bacterial lyasesSPICKENREITHER, Martin; BRAUN, Stephan; BERNHARDT, Günther et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 20, pp 5313-5316, issn 0960-894X, 4 p.Article

Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agentsLOTTNER, Christian; BART, Karl-Christian; BERNHARDT, Günther et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 10, pp 2079-2089, issn 0022-2623Article

Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonistsWEISS, Stefan; KELLER, Max; BERNHARDT, Gunther et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 22, pp 9858-9866, issn 0968-0896, 9 p.Article

Fluorescence-and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligandsZIEMEK, Ralf; BRENNAUER, Albert; SCHNEIDER, Erich et al.European journal of pharmacology. 2006, Vol 551, Num 1-3, pp 10-18, issn 0014-2999, 9 p.Article

[1,2-Bis(2,6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer: Mode of action I: Antitumor activity due to the reduction of the endogenous estrogen levelSCHERTL, Sabine; HARTMANN, Rolf W; SCHÖNENBERGER, Helmut et al.Archiv der Pharmazie (Weinheim). 2004, Vol 337, Num 6, pp 335-348, issn 0365-6233, 14 p.Article

Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and gradeWEISS, Thomas S; BERNHARDT, Günther; BUSCHAUER, Armin et al.International journal of colorectal disease (Print). 2002, Vol 17, Num 6, pp 381-387, issn 0179-1958Article

Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological toolsKELLER, Max; ERDMANN, Daniela; POP, Nathalie et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 9, pp 2859-2878, issn 0968-0896, 20 p.Article

Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyaseBRAUN, Stephan; BOTZKI, Alexander; SALMEN, Sunnhild et al.European journal of medicinal chemistry. 2011, Vol 46, Num 9, pp 4419-4429, issn 0223-5234, 11 p.Article

Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiaeSALMEN, Sunnhild; HOECHSTETTER, Julia; KÄSBAUER, Christian et al.Planta medica. 2005, Vol 71, Num 8, pp 727-732, issn 0032-0943, 6 p.Article

Synthesis and pharmacological activity of fluorescent histamine H2 receptor antagonists related to potentidineLIANTAO LI; KRACHT, Julia; SHIQI PENG et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 10, pp 1717-1720, issn 0960-894X, 4 p.Article

Preparation of fluorescent nonpeptidic neuropeptidey receptor ligands: Analogues of the quinazoline-type anti-obesity Y5 antagonist CGP 71683ALIANTAO LI; MAYER, Matthias; SCHNEIDER, Erich et al.Archiv der Pharmazie (Weinheim). 2003, Vol 336, Num 12, pp 585-590, issn 0365-6233, 6 p.Article

Establishment and characterization of new murine breast cancer cell linesBERNHARDT, Günther; BECKENLEHNER, Karin; SPRUSS, Thilo et al.Archiv der Pharmazie (Weinheim). 2002, Vol 335, Num 2-3, pp 55-68, issn 0365-6233Article

Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivityGHORAI, Prasanta; KRAUS, Anja; BIRNKAMMER, Tobias et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 10, pp 3173-3176, issn 0960-894X, 4 p.Article

Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from the p-Glycoprotein (ABCB1) Modulator TariquidarKÜHNLE, Matthias; EGGER, Michael; MULLER, Christine et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 4, pp 1190-1197, issn 0022-2623, 8 p.Article

1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes : New biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic propertiesSCHERTL, Sabine; HARTMANN, Rolf W; BATZL-HARTMANN, Christine et al.Archiv der Pharmazie (Weinheim). 2001, Vol 334, Num 4, pp 125-137, issn 0365-6233Article

  • Page / 1